If we show outstanding phase 2 in acne and phase 2 in dermatitis venture capitalist will be over this like there is no tomorrow. For them it is peanuts of cost compared to the future prescription retail benefit. It is that simple my friends.
The antibacterial product was to me an idea out of left field but teaming with the smart people was a very sensible move. I only hope that their studies have wasted plenty of agar petri dishes and found that our product has some real benefits with many bugs. For me it is a bonus really but could provide a very nice fillip.
Ann: Investor Presentation, page-36
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.020(5.97%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 36.0¢ | 33.3¢ | $2.622M | 7.530M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 106888 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 462320 | 5 |
View Market Depth
| Last trade - 16.10pm 26/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
